AMICUS THERAPEUTICS INC
NASDAQ: FOLD (Amicus Therapeutics, Inc.)
最近更新时间: 9小时之前14.31
0.01 (0.07%)
| 前收盘价格 | 14.30 |
| 收盘价格 | 14.32 |
| 成交量 | 5,157,081 |
| 平均成交量 (3个月) | 11,137,286 |
| 市值 | 4,489,103,872 |
| 预期市盈率 (P/E Forward) | 17.61 |
| 价格/销量 (P/S) | 7.35 |
| 股市价格/股市净资产 (P/B) | 19.46 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业毛利率 | -5.41% |
| 营业利益率 (TTM) | -6.35% |
| 稀释每股收益 (EPS TTM) | -0.090 |
| 季度收入增长率 (YOY) | 13.40% |
| 总债务/股东权益 (D/E MRQ) | 229.11% |
| 流动比率 (MRQ) | 3.34 |
| 营业现金流 (OCF TTM) | 3.56 M |
| 杠杆自由现金流 (LFCF TTM) | 29.27 M |
| 资产报酬率 (ROA TTM) | 3.95% |
| 股东权益报酬率 (ROE TTM) | -18.12% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Amicus Therapeutics, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -4.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.13 |
|
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.72% |
| 机构持股比例 | 103.25% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Vestal Point Capital, Lp | 30 Sep 2025 | 9,750,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 14.50 (Jefferies, 1.33%) | 保留 |
| 14.50 (Leerink Partners, 1.33%) | 保留 | |
| 14.50 (Citigroup, 1.33%) | 保留 | |
| 14.50 (Cantor Fitzgerald, 1.33%) | 保留 | |
| 中 | 14.50 (1.33%) | |
| 平均值 | 14.50 (1.33%) | |
| 总计 | 4 保留 | |
| 平均价格@调整类型 | 14.23 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Jefferies | 22 Jan 2026 | 14.50 (1.33%) | 保留 | 14.27 |
| Leerink Partners | 29 Dec 2025 | 14.50 (1.33%) | 保留 | 14.25 |
| Citigroup | 22 Dec 2025 | 14.50 (1.33%) | 保留 | 14.21 |
| 17 Dec 2025 | 17.00 (18.80%) | 购买 | 11.00 | |
| Cantor Fitzgerald | 19 Dec 2025 | 14.50 (1.33%) | 保留 | 14.18 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合